News & Articles

The new facilities are designed to enable IVD and point of care businesses to develop and manufacture assays at scale

Expert scientists at the University of Manchester are studying ways to reduce risks of serious problems in pregnancy

The algorithm affords the possibility to select patients likely to benefit from targeted therapies with quicker turnarounds compared to current methods

Could persister cells provide new hope in the battle against antibiotic resistance?

Which new products helped to accelerate your lab work this year?

We’ve rounded up the latest clinical news and technological advancements which made waves at this year’s conference

Keep up to date with the latest technologies and techniques advancing clinical diagnostics

QIAreach SARS-CoV-2 Antigen Test, developed in collaboration with Ellume, provides accurate and objective results in 2 to 15 minutes

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks

Patients with underlying heart problems are more than four times as likely to die from COVID-19

Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home

Researchers have cataloged for the first time

It is hoped this therapy will be a breakthrough for patients suffering from hereditary transthyretin (ATTR) amyloidosis

The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories

Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic

Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis

Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models

Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process